Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1995 5
1996 7
1997 5
1998 14
1999 13
2000 6
2001 7
2002 9
2003 5
2004 1
2005 1
2006 1
2007 3
2008 4
2009 4
2010 3
2011 2
2012 1
2013 1
2014 2
2015 2
2016 3
2017 2
2018 1
2021 1
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
[Stroke--a continuing epidemic].
Raicević R. Raicević R. Vojnosanit Pregl. 2009 Oct;66(10):777-8. Vojnosanit Pregl. 2009. PMID: 19938753 Serbian. No abstract available.
Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020.
Aguiar de Sousa D, Wilkie A, Norrving B, Macey C, Bassetti C, Tiu C, Roth G, Lunde G, Christensen H, Fiehler J, Pezzella FR, Dichgans M, Roaldsen MB, Kelly P, Mikulik R, Sacco S, Caso V, Fischer U; Steering Committee for the Implementation of the Stroke Action Plan in Europe. Aguiar de Sousa D, et al. Eur Stroke J. 2023 Sep;8(3):618-628. doi: 10.1177/23969873231186042. Epub 2023 Jul 11. Eur Stroke J. 2023. PMID: 37431768 Free PMC article.
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators. Fox RJ, et al. N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328. N Engl J Med. 2012. PMID: 22992072 Free article. Clinical Trial.
[The Fahr syndrome].
Raicević R, Jovicić A, Djordjević D, Dincić E, Marković Lj. Raicević R, et al. Vojnosanit Pregl. 1998 Mar-Apr;55(2):219-23. Vojnosanit Pregl. 1998. PMID: 9623350 Serbian.
[Progressive multifocal leukoencephalopathy].
Raicević R, Jovicić A, Djordjević D, Dincić V, Marković Lj. Raicević R, et al. Vojnosanit Pregl. 1998 Jan-Feb;55(1):95-100. Vojnosanit Pregl. 1998. PMID: 9612133 Serbian.
Uremic osteopathy.
Katić V, Dojcinov D, Strahinjić S, Savić V, Babić R, Marković Z, Raicević R. Katić V, et al. Among authors: raicevic r. Acta Med Iugosl. 1975;29(3):271-80. Acta Med Iugosl. 1975. PMID: 1146605 No abstract available.
105 results